Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
Authors:
- Mohamed ZaidMZMohamed Zaid
- Lauren WidmannLWLauren Widmann
- Annie DaiADAnnie Dai
- Kevin SunKSKevin Sun
- Jie ZhangJZJie Zhang
- Jun ZhaoJZJun Zhao
- Mark W. HurdMHMark W. Hurd
- Gauri R. VaradhacharyGVGauri R. Varadhachary
- Robert A. WolffRWRobert A. Wolff
- Anirban MaitraAMAnirban Maitra
- Matthew H. G. KatzMKMatthew H. G. Katz
- Joseph M. HermanJHJoseph M. Herman
Open Access
Abstract
Previously, we characterized qualitative imaging-based subtypes of pancreatic ductal adenocarcinoma (PDAC) on computed tomography (CT) scans. Conspicuous (high delta) PDAC tumors are more likely to have aggressive biology and poorer clinical outcomes compared to inconspicuous (low delta) tumors. Here, we developed a quantitative classification of this imaging-based subtype (quantitative delta; q-delta). Retrospectively, baseline pancreatic protocol CT scans of three cohorts (cohort#1 = 101, cohort#2 = 90 and cohort#3 = 16 [external validation]) of patients with PDAC were qualitatively classified into high and low delta. We used a voxel-based method to volumetrically quantify tumor enhancement while referencing normal-pancreatic-parenchyma and used machine learning-based analysis to build a predictive model. In addition, we quantified the stromal content using hematoxylin- and eosin-stained treatment-naïve PDAC sections. Analyses revealed that PDAC quantitative enhancement values are predictive of the qualitative delta scoring and were used to build a classification model (q-delta). Compared to high q-delta, low q-delta tumors were associated with improved outcomes, and the q-delta class was an independent prognostic factor for survival. In addition, low q-delta tumors had higher stromal content and lower cellularity compared to high q-delta tumors. Our results suggest that q-delta classification provides a clinically and biologically relevant tool that may be integrated into ongoing and future clinical trials.Keywords
Funding Information
- University of Texas MD Anderson Cancer Center (Moonshots program)
- Pancreatic Cancer Action Network (16-65-SING)
- Stand Up 2 Cancer (SU2C-AACR-DT25-17)
- National Cancer Institute (Cancer Center Support (Core) Grant CA016672)
- National Institutes of Health (U54CA210181-01, U54CA143837 and U01CA196403, 5U01CA200468, 1-U01-CA214263-01A1, 5P50CA221707-02, 5R01CA221971-03, R01-CA218004-01A1, 5R01CA203890-05)
- GE Healthcare (GE Healthcare)
- Center of Advanced Biomedical Imaging (CABI)
- Project Purple (Project Purple)
- Andrew Sabin Family Foundation (Fellowship)
- Philips Healthcare (Philips Healthcare)
- Sheikh Ahmed Center for Pancreatic Cancer Research (Sheikh Ahmed Center for Pancreatic Cancer Research)
This publication has 35 references indexed in Scilit:
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information RepositoryJournal of Digital Imaging, 2013
- Imaging Abdominal and Flank Trauma2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant ChemoradiationAnnals of Surgical Oncology, 2010
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathologyAbdominal Radiology, 2008
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of DiseaseJournal of the American College of Surgeons, 2008
- Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma.American Journal of Roentgenology, 1999
- Morphometric analysis of white matter lesions in MR images: method and validationIEEE Transactions on Medical Imaging, 1994